Psychiatry & Neurology, Sleep Medicine · Los Angeles, CA
NPI
1326332917
Since 2011
Specialty
Psychiatry & Neurology, Sleep Medicine
Code 2084S0012X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8635 W 3rd St Ste 850w
Los Angeles, CA, 90048
Phone (310) 385-6016
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
11,609 services
Medicare patients, 2024
388
Average age 71
Drug cost, 2024
$414K
1,604 prescriptions
Company payments, 2025
$28.63
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arun Ramachandran was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,795 times for 15 patients. In total Arun Ramachandran billed 11,609 services in 23 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,795 | 15 | $4.97 | $49K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 678 | 22 | $5.37 | $3,640 |
| 99214 Office E&M - Established | Office | 211 | 126 | $102.06 | $22K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 197 | 196 | $76.41 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 141 | 115 | $13.57 | $1,914 |
| 99215 Office E&M - Established | Office | 140 | 75 | $151.47 | $21K |
| 64450 Musculoskeletal | Office | 113 | 23 | $80.24 | $9,067 |
| 64405 Musculoskeletal | Office | 112 | 22 | $46.24 | $5,179 |
| 20553 Musculoskeletal | Office | 70 | 20 | $24.97 | $1,748 |
| 64615 Musculoskeletal | Office | 46 | 15 | $120.03 | $5,522 |
| 99205 Office E&M - New | Office | 40 | 40 | $169.10 | $6,764 |
| 95810 Sleep Study | Office | 13 | 12 | $98.09 | $1,275 |
By year: 2022 $124K for 8,923 services; 2023 $160K for 14,605 services; 2024 $146K for 11,609 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arun Ramachandran prescribed most often to Medicare patients was Gabapentin, with 106 prescriptions and refills. In total Arun Ramachandran wrote 1,604 Medicare prescriptions that cost $414K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 106 | 197 | 35 | $2,145 |
| Pregabalin Generic | 81 | 115 | 15 | $3,364 |
| Zolpidem Tartrate Generic | 70 | 110 | 17 | $417 |
| Aimovig Autoinjector Erenumab-Aooe | 53 | 63 | Under 11 | $46K |
| Modafinil Generic | 49 | 92 | 13 | $3,155 |
| Quetiapine Fumarate Generic | 41 | 91 | Under 11 | $723 |
| Sumatriptan Succinate Generic | 40 | 50 | Under 11 | $1,209 |
| Sunosi Solriamfetol Hcl | 39 | 63 | Under 11 | $55K |
| Rizatriptan Rizatriptan Benzoate | 38 | 50 | 11 | $1,337 |
| Trazodone Hcl Generic | 37 | 103 | 14 | $338 |
| Baclofen Generic | 35 | 93 | 13 | $966 |
| Cyclobenzaprine Hcl Generic | 35 | 43 | 12 | $408 |
| Armodafinil Generic | 34 | 42 | Under 11 | $1,497 |
| Nortriptyline Hcl Generic | 33 | 61 | Under 11 | $552 |
| Nurtec Odt Rimegepant Sulfate | 32 | 32 | Under 11 | $31K |
Brand drugs: - claims; generic drugs: 1,344 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arun Ramachandran $28.63 ($28.63 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $28.63.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $28.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.